Is a complete CSBR research report available?

No complete published report is available for Champions Oncology, Inc. (CSBR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · USD

$6.00

-0.13 (-2.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CSBR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	83.3M
Revenue (ttm)	57.9M
Net income (ttm)	-2.3M
EPS (ttm)	-$0.17
Shares out	13.9M
Volume	1,405.089
Beta	0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.9M
Net income (ttm): -2.3M
EPS (ttm): -$0.17
Market cap: 83.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CSBR indicators

Market & fundamental data

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000771856
Company name	Champions Oncology, Inc.
Country	United States
Country code	US
Cusip	15870P307
Employees	213
Employees Change	3%
Employees Change Percent	1.43
Enterprise value	$77.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1986-03-25
Isin	US15870P3073
Last refreshed	2026-07-24
Market cap	$83.3M
Market cap category	Micro-Cap
Price	$6
Price currency	USD
Rev Per Employee	272,042.25x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2836
Symbol	CSBR
Website	https://www.championsoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.95%
EV Sales Forward	1.24x
EV/FCF	20.22x
EV/Sales	1.33x
FCF yield	4.81%
P/B ratio	19.88x
P/S ratio	1.37x
PS Forward	1.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.53%
EBITDA Margin	-4.53%
FCF margin	6.59%
Gross margin	45.88%
Gross Profit	$26.6M
Gross Profit Growth	-12.04%
Gross Profit Growth Q	-25.88%
Gross Profit Growth3 Y	1.72%
Gross Profit Growth5 Y	7.43%
Net Income	$-2.3M
Net Income Growth Years	1%
Pretax Margin	-4.14%
Profit Margin	-4.04%
Profit Per Employee	$-11,000
Profitable Years	1
ROA	-4.7
Roa5y	-1.96
ROCE	-33.78
ROE	-47.59
Roe5y	-18.94
ROIC	-131.6
Roic5y	-8.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.5%
Cagr15y	-3.48%
Cagr1y	-23.53%
Cagr20y	16.16%
Cagr3y	-4.87%
Cagr5y	-10.28%
EPS Growth Years	1
FCF Growth3 Y	10.32%
OCF Growth3 Y	-6.98%
OCF Growth5 Y	9.09%
Revenue Growth	-1.1x
Revenue Growth Q	-2.82x
Revenue Growth Years	1x
Revenue Growth3 Y	2.58x
Revenue Growth5 Y	8.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.96
Assets	$28.4M
Cash	$7.1M
Current Assets	$20.2M
Current Liabilities	$20.7M
Debt	$5M
Debt Equity	$1.14
Debt FCF	$1.31
Equity	$4.4M
Interest Coverage	-97.22
Liabilities	$24.1M
Long Term Assets	$8.3M
Long Term Liabilities	$3.4M
Net Cash	$2.1M
Net Cash By Market Cap	$2.68
Net Debt Equity	$-0.49
Net Debt FCF	$-0.56
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$0.28
WACC	6.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.98
Net Working Capital	$-6M
Quick ratio	0.93
Working Capital	$-492,000
Working Capital Turnover	$-174

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.39%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	196.96%
1Y total return	-23.52%
200-day SMA	6.31
3Y total return	-13.92%
50-day SMA	6.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-41.86%
All Time High	33
All Time High Change	-81.82%
All Time High Date	1992-07-24
All Time Low	0.07
All Time Low Change	8,233.33%
All Time Low Date	2003-02-19
ATR	0.32
Beta	0.39
Beta1y	-0.1
Beta2y	0.46
Ch YTD	-13.17
High	6
High52	8.74
High52 Date	2025-09-15
High52ch	-31.35%
Low	5.71
Low52	5.5
Low52 Date	2026-03-13
Low52ch	9.09%
Ma50ch	-0.7%
Price vs 200-day SMA	-4.97%
RSI	49.43
RSI Monthly	47.46
RSI Weekly	47.36
Sharpe ratio	-0.22x
Sortino ratio	-0.23
Total Return	1.39%
Tr YTD	-13.17
Tr15y	-41.18%
Tr1m	-4%
Tr1w	2.74%
Tr3m	-0.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	12,886,000x
Earnings Revenue Estimate Growth	4.3x
Operating Income	$-2.2M
Operating margin	-3.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,070,933%
Float Percent	43.72%
Net Borrowing	-154,000
Shares Insiders	26.5%
Shares Institutions	41.18%
Shares Out	13,886,826
Shares Qo Q	-3.95%
Shares Yo Y	-1.39%
Short Float	1.27%
Short Ratio	11.29
Short Shares	0.55

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.8M
Average Volume	7,654.8x
Bv Per Share	0.31
CAPEX	$-578,000
Ch10y	196.9
Ch15y	-41.18
Ch1m	-4
Ch1w	2.74
Ch1y	-23.52
Ch20y	1,900
Ch3m	-0.17
Ch3y	-13.92
Ch5y	-41.86
Ch6m	-13.42
Change	-2.12%
Change From Open	5.08
Close	6.13
Days Gap	-6.85
Depreciation Amortization	1,450,000
Dollar Volume	8,430.5
Earnings Date	2026-07-27
Earnings Time	amc
EBIT	$-2.6M
EBITDA	$-2.6M
EPS	$-0.17
F Score	2
FCF	$3.8M
FCF EV Yield	4.95x
FCF Per Share	$0.27
Financing CF	86,000
Fiscal Year End	April
Founded	1,985
Goodwill	335,000
Income Tax	$-55,000
Investing CF	-555,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2026-01-31
Last Split Date	2015-08-12
Last Split Type	Reverse
Last10k Filing Date	2025-07-23
Ma150	6.22
Ma150ch	-3.6%
Ma20	6
Ma20ch	-0.07%
Net CF	3,925,000
Next Earnings Date	2026-07-27
Open	5.71
Optionable	Yes
P FCF Ratio	20.78
P OCF Ratio	18.05
Position In Range	100
Ppne	7,731,000
Price Date	2026-07-23
Ptbv Ratio	20.08
Relative Volume	0.18x
Revenue	57,945,000x
SBC By Revenue	1.74x
Share Based Comp	1,011,000
Tax By Revenue	-0.09x
Tr20y	1,900%
Tr6m	-13.42%
Us State	New Jersey
Volume	1,405.1
Z Score	0.35

Champions Oncology, Inc. (CSBR)

Coverage state: Market snapshot only — no published research

Generate the first CSBR analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CSBR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSBR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CSBR

Frequently asked questions